SCHEMBL10248358

SCHEMBL10248358

O=C(c1nccs1)c1ccccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.56
▸ BDKRB1 P46663 6/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ PTGS1 P23219 1/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ SLC40A1 Q9NP59 4/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ METAP2 P50579 2/20 0.45
▸ G6PD P11413 1/20 0.45
▸ NFKBIA P25963 1/20 0.45
▸ AGTR1 P30556 1/20 0.45
▸ METAP1 P53582 1/20 0.45
▸ GLO1 Q04760 1/20 0.45
▸ PAX8 Q06710 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5998220 0.87 CCR9 (0.53) GRM4BDKRB1KDM4EALDH1A1GLO1
SCHEMBL10248015 0.80 BDKRB1 (0.56) BDKRB1KMT2ATSHRSLC40A1KDM4E
SCHEMBL10251853 0.77 BDKRB1 (0.74) GRM4BDKRB1KMT2ATSHRSLC40A1
SCHEMBL10248369 0.77 LMNA (0.55) BDKRB1CYP3A4KMT2ATSHRKDM4E
SCHEMBL31305 0.76 BDKRB1 (0.72) BDKRB1CYP3A4KMT2ATSHRKDM4E
SCHEMBL10248265 0.76 BDKRB1 (0.73) BDKRB1KMT2AALDH1A1HPGD
SCHEMBL10248374 0.75 BDKRB1 (0.49) BDKRB1CYP3A4KMT2ATSHRKDM4E
SCHEMBL10247992 0.75 KMT2A (0.49) BDKRB1CYP3A4KMT2ATSHRSLC40A1
SCHEMBL13146414 0.75 ALDH1A1 (0.61) BDKRB1KMT2ATSHRKDM4EALDH1A1
SCHEMBL10248276 0.74 BDKRB1 (0.57) BDKRB1KMT2ATSHRSLC40A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10364240-B2 Aryl sulfonamides ChemoCentryx. Inc. (US) 2019-07-30 — — US disclosed
US-9890148-B2 Aryl sulfonamides CHEMOCENTRYX, INC. (US) 2018-02-13 — — US disclosed
US-20150080351-A1 ARYL SULFONAMIDES CHEMOCENTRYX, INC. 2015-03-19 — — US disclosed
US-20130267492-A1 ARYL SULFONAMIDES CHEMOCENTRYX, INC. (US) 2013-10-10 — — US disclosed
US-20120014997-A1 ARYL SULFONAMIDES UNGASHE SOLOMON (US) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10364240-B2 Aryl sulfonamides CCR9, CCR1, CCR2 GRM4 897/4885BDKRB1 429/4885CYP3A4 1923/4885
US-20120014997-A1 ARYL SULFONAMIDES CCR9, CCR1, CCR2 GRM4 897/4885BDKRB1 429/4885CYP3A4 1923/4885
US-20150080351-A1 ARYL SULFONAMIDES CCR9, CCR1, CCR2 GRM4 897/4885BDKRB1 429/4885CYP3A4 1923/4885
US-20130267492-A1 ARYL SULFONAMIDES CCR9, CCR1, CCR2 GRM4 897/4885BDKRB1 429/4885CYP3A4 1923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback